heXembio

Recoding early human development for longevity

New York, United States · Founded 2024 · $17.9M raised

Headquarters
New York, New York
Employees
1–10
Founded
2024
Business Model
B2B
Website
hexemb.io
Total Funding
$17.9M
Last Round
$10.4M SeedApr 2026
Rounds
2

About

heXembio is a longevity therapeutics company developing the world's first rejuvenated hematopoietic stem cell therapy. Its platform restores the regenerative power of aged blood stem cells using a synthetic biology approach validated in peer-reviewed research published in Nature. The technology targets aging, immune health, and hematological conditions.

Summary

heXembio is a Biotech company based in New York, United States, founded in 2024. It has raised $17.9M in total across 2 rounds, most recently a $10.4M Seed round in Apr 2026. Investors include Draper Associates, SOSV and Zentynel.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

SeedApr 2026
$10.4M

Sign up to see all 2 rounds

Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

heXembio on Indexed.vc
<a href="https://indexed.vc/companies/hexembio"><img src="https://indexed.vc/api/badge/company/hexembio" alt="heXembio on Indexed.vc" width="260" height="76" /></a>